Relacorilant, developed by Corcept Therapeutics (NASDAQ: CORT), is a selective glucocorticoid receptor (GR) antagonist designed to control hypercortisolism symptoms in endogenous Cushing's syndrome.

The researchers concluded from their analysis that “exhaled propanoic and nonanoic acids may serve as complementary non-invasive biomarkers for monitoring controlled asthma, independently of tobacco ...

The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has declined to ...

Discover how endogenous growth theory explains economic growth from within through innovation, human capital, and internal factors, impacting nations' prosperity.

Research reveals why AI systems can't become conscious—and what radically different computing substrates would be needed to ...

Now I know that there are many more things in heaven and earth than I’ve dreamt of. I never expected to find a Baptist-inspired project that ...

Controlled heat treatment can provide a powerful and flexible tool to enhance wheat flour for cake production.

The Unity Accord, signed 38 years ago today, encouraged the unity of Zimbabwe’s two main national liberation movements, ...

Scientists are testing a strikingly simple idea for calming some of the brain’s most stubborn seizures: remove the aging ...

The study included 62 overweight adults. Each person followed two diets during the study: one group started with a ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...